This live program provides 8 hours of the required 24 hours education needed to obtain the waiver to prescribe buprenorphine. AAPA is an approved provider by CSAT/SAMHSA of DATA 2000 training.
Once you have completed the 8-hour live portion, the remaining 16 hours can be completed online in AAPA’s Learning Central.
This course is $75 and you must pre-register. Sign up when you register for AAPA 2018 or log in at any time to your registration dashboard to register. This course is only available for current AAPA Fellow members.
Contact email@example.com with questions.
Overview of Legislation
On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified PAs and NPs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.
To qualify, PAs must:
- Be licensed under state law to prescribe schedule III, IV, or V medications for pain
- Complete not less than 24 hours of appropriate education through a qualified provider
- Through other training or experience, demonstrate the ability to treat and manage OUD
- If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD